

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.71347999 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.71347999 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.45592389 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.45592389 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.98566161 |
| 6 | lysine metabolic process (GO:0006553) | 5.73496808 |
| 7 | lysine catabolic process (GO:0006554) | 5.73496808 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.62144331 |
| 9 | cysteine metabolic process (GO:0006534) | 5.49985801 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 5.45202243 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40258813 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.35411742 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.35411742 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.35411742 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 5.26459418 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.24104360 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.20148200 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.12247111 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.07082588 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.04781524 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.03693549 |
| 22 | homocysteine metabolic process (GO:0050667) | 4.85956713 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.82647155 |
| 24 | amino-acid betaine metabolic process (GO:0006577) | 4.76147419 |
| 25 | urea cycle (GO:0000050) | 4.56712686 |
| 26 | urea metabolic process (GO:0019627) | 4.56712686 |
| 27 | short-chain fatty acid metabolic process (GO:0046459) | 4.55459470 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.50663214 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 4.47833819 |
| 30 | fatty acid beta-oxidation (GO:0006635) | 4.45190925 |
| 31 | * alpha-amino acid catabolic process (GO:1901606) | 4.40139362 |
| 32 | acetyl-CoA metabolic process (GO:0006084) | 4.37902334 |
| 33 | oxidative demethylation (GO:0070989) | 4.34710659 |
| 34 | 2-oxoglutarate metabolic process (GO:0006103) | 4.34459261 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.34287555 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 4.30448701 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.30425624 |
| 38 | drug transmembrane transport (GO:0006855) | 4.28984373 |
| 39 | fatty acid oxidation (GO:0019395) | 4.27948889 |
| 40 | bile acid metabolic process (GO:0008206) | 4.26708234 |
| 41 | * cellular amino acid catabolic process (GO:0009063) | 4.23571643 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.23410077 |
| 43 | lipid oxidation (GO:0034440) | 4.21285197 |
| 44 | cellular modified amino acid catabolic process (GO:0042219) | 4.21077066 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 4.17891532 |
| 46 | urate metabolic process (GO:0046415) | 4.16047435 |
| 47 | protein carboxylation (GO:0018214) | 4.14829446 |
| 48 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.14829446 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.13335903 |
| 50 | ethanol oxidation (GO:0006069) | 4.10674310 |
| 51 | fatty acid catabolic process (GO:0009062) | 4.09938433 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 4.09595250 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.09055561 |
| 54 | glutamate metabolic process (GO:0006536) | 4.02394755 |
| 55 | serine family amino acid metabolic process (GO:0009069) | 3.99790885 |
| 56 | monocarboxylic acid catabolic process (GO:0072329) | 3.99189395 |
| 57 | drug catabolic process (GO:0042737) | 3.98654736 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.98652740 |
| 59 | acylglycerol homeostasis (GO:0055090) | 3.98652740 |
| 60 | * organic acid catabolic process (GO:0016054) | 3.92833671 |
| 61 | * carboxylic acid catabolic process (GO:0046395) | 3.92833671 |
| 62 | * valine metabolic process (GO:0006573) | 3.91289899 |
| 63 | regulation of complement activation (GO:0030449) | 3.90579433 |
| 64 | carnitine metabolic process (GO:0009437) | 3.90386597 |
| 65 | regulation of fibrinolysis (GO:0051917) | 3.89382619 |
| 66 | * branched-chain amino acid catabolic process (GO:0009083) | 3.88666286 |
| 67 | biotin metabolic process (GO:0006768) | 3.87273205 |
| 68 | ketone body metabolic process (GO:1902224) | 3.86620171 |
| 69 | coenzyme catabolic process (GO:0009109) | 3.86555219 |
| 70 | * branched-chain amino acid metabolic process (GO:0009081) | 3.85696144 |
| 71 | reverse cholesterol transport (GO:0043691) | 3.82849737 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.80980975 |
| 73 | cellular glucuronidation (GO:0052695) | 3.80683498 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 3.78641905 |
| 75 | S-adenosylmethionine metabolic process (GO:0046500) | 3.74547398 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.73698985 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72469179 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 3.72469179 |
| 79 | macromolecular complex remodeling (GO:0034367) | 3.72469179 |
| 80 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.72347758 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.72155431 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 3.66129125 |
| 83 | glycine metabolic process (GO:0006544) | 3.65788072 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 3.63149444 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 3.62669409 |
| 86 | amine catabolic process (GO:0009310) | 3.62669409 |
| 87 | negative regulation of sterol transport (GO:0032372) | 3.61110372 |
| 88 | negative regulation of cholesterol transport (GO:0032375) | 3.61110372 |
| 89 | fatty acid transmembrane transport (GO:1902001) | 3.60701898 |
| 90 | ethanol metabolic process (GO:0006067) | 3.57952519 |
| 91 | exogenous drug catabolic process (GO:0042738) | 3.57201684 |
| 92 | tricarboxylic acid metabolic process (GO:0072350) | 3.56254308 |
| 93 | drug transport (GO:0015893) | 3.53155720 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.52336792 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.52100374 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.51563611 |
| 97 | phenylpropanoid metabolic process (GO:0009698) | 3.46679086 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.45400755 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.45400755 |
| 100 | response to mercury ion (GO:0046689) | 3.41388951 |
| 101 | positive regulation of fatty acid oxidation (GO:0046321) | 3.40090175 |
| 102 | bile acid and bile salt transport (GO:0015721) | 3.39381728 |
| 103 | drug metabolic process (GO:0017144) | 3.38177718 |
| 104 | phospholipid efflux (GO:0033700) | 3.37435050 |
| 105 | C4-dicarboxylate transport (GO:0015740) | 3.33277739 |
| 106 | regulation of cholesterol metabolic process (GO:0090181) | 3.32295106 |
| 107 | * small molecule catabolic process (GO:0044282) | 3.31355382 |
| 108 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.26404508 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.15064014 |
| 110 | gamma-aminobutyric acid transport (GO:0015812) | 3.11462770 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.09428417 |
| 112 | heme transport (GO:0015886) | 3.08704820 |
| 113 | amino acid salvage (GO:0043102) | 3.07933826 |
| 114 | L-methionine salvage (GO:0071267) | 3.07933826 |
| 115 | L-methionine biosynthetic process (GO:0071265) | 3.07933826 |
| 116 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04210719 |
| 117 | arginine metabolic process (GO:0006525) | 3.03271822 |
| 118 | alkaloid metabolic process (GO:0009820) | 2.99968635 |
| 119 | sodium-independent organic anion transport (GO:0043252) | 2.95340960 |
| 120 | aldehyde catabolic process (GO:0046185) | 2.94942218 |
| 121 | xenobiotic catabolic process (GO:0042178) | 2.92226788 |
| 122 | flavonoid metabolic process (GO:0009812) | 2.89514208 |
| 123 | cholesterol efflux (GO:0033344) | 2.74548829 |
| 124 | behavioral response to nicotine (GO:0035095) | 2.71346736 |
| 125 | axon ensheathment in central nervous system (GO:0032291) | 2.67568468 |
| 126 | central nervous system myelination (GO:0022010) | 2.67568468 |
| 127 | indole-containing compound metabolic process (GO:0042430) | 2.66802348 |
| 128 | arginine catabolic process (GO:0006527) | 2.61702079 |
| 129 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.60238482 |
| 130 | iron coordination entity transport (GO:1901678) | 2.56395329 |
| 131 | neurotransmitter catabolic process (GO:0042135) | 2.55874864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.36973837 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.88490333 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.30494505 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.83761395 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.32703168 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.60850569 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.87082614 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.72069389 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36144392 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15585349 |
| 11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.13405807 |
| 12 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.91171832 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.30678839 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.27244003 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.22003145 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.19524214 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13017574 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.09549920 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09009260 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.08588357 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.08544904 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02151694 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1967356 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97301430 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.86534801 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84967556 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84854469 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81418618 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78292941 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74118606 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.65784417 |
| 32 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64610943 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54456640 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53445289 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53262921 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51991221 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51643651 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47288813 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45729766 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44109682 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.44077811 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43790659 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41739289 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40469809 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39738392 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39455790 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38815314 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35083938 |
| 49 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34690719 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34051551 |
| 51 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33452346 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.32465997 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31715018 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29726590 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27251013 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27208939 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26468066 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25753355 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23027933 |
| 60 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.22874453 |
| 61 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.20869015 |
| 62 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20560702 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19402609 |
| 64 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17119890 |
| 65 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17119890 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16034439 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15525037 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14368574 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14191006 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.13742332 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13692966 |
| 72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13134958 |
| 73 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.11589777 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11468081 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11468081 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10829739 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10595745 |
| 78 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.10423182 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10045321 |
| 80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09841548 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09633789 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09459992 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09451060 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09300980 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08702660 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08225001 |
| 87 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07948076 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07833618 |
| 89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07308351 |
| 90 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07214032 |
| 91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06839333 |
| 92 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06827860 |
| 93 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04974892 |
| 94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04525365 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04205599 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03849004 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03812485 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02339867 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02339867 |
| 100 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01806134 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98949265 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98714757 |
| 103 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98255014 |
| 104 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98017481 |
| 105 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97812705 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97682453 |
| 107 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97627321 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97593830 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96915488 |
| 110 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.96591517 |
| 111 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.96591517 |
| 112 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96330931 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96162858 |
| 114 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95955243 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95228200 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91975101 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90241796 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90241796 |
| 119 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90192074 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88418978 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88398828 |
| 122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84830825 |
| 123 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83200771 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82032920 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81992322 |
| 126 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81012428 |
| 127 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81012428 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78421140 |
| 129 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77567750 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76679378 |
| 131 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75909612 |
| 132 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.74842079 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74194933 |
| 134 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72183362 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.71994625 |
| 136 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71110359 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71012751 |
| 138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70112890 |
| 139 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70061139 |
| 140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66887628 |
| 141 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65070969 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63813400 |
| 143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63703065 |
| 144 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63478855 |
| 145 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.61936271 |
| 146 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61665645 |
| 147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61456040 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.61343421 |
| 149 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.60993287 |
| 150 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.60203850 |
| 151 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59797790 |
| 152 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59538095 |
| 153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59483403 |
| 154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.58716747 |
| 155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57298002 |
| 156 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.56949452 |
| 157 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56653438 |
| 158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.55125785 |
| 159 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55099017 |
| 160 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.54648322 |
| 161 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53840688 |
| 162 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53634448 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53619501 |
| 164 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.53603346 |
| 165 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.53396174 |
| 166 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50873942 |
| 167 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50503254 |
| 168 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.50150742 |
| 169 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.49433268 |
| 170 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.49015488 |
| 171 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48721265 |
| 172 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46698631 |
| 173 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46562587 |
| 174 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.46145059 |
| 175 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.45567561 |
| 176 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.45567038 |
| 177 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44785264 |
| 178 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.44149769 |
| 179 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44062123 |
| 180 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43726732 |
| 181 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.43525825 |
| 182 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.43120853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.35758590 |
| 2 | MP0005360_urolithiasis | 7.30683436 |
| 3 | MP0005365_abnormal_bile_salt | 5.53683316 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.37848974 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.52745604 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.58015499 |
| 7 | MP0003252_abnormal_bile_duct | 3.41609185 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.38464727 |
| 9 | MP0005332_abnormal_amino_acid | 3.35244744 |
| 10 | MP0003195_calcinosis | 2.97129298 |
| 11 | MP0009840_abnormal_foam_cell | 2.55428300 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.53287241 |
| 13 | MP0005083_abnormal_biliary_tract | 2.48291024 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.41875269 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.37030443 |
| 16 | MP0005670_abnormal_white_adipose | 2.35373412 |
| 17 | MP0003880_abnormal_central_pattern | 2.29355486 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.22669195 |
| 19 | MP0000609_abnormal_liver_physiology | 1.98351707 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.95130941 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.86874063 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.84625412 |
| 23 | MP0004130_abnormal_muscle_cell | 1.83856121 |
| 24 | MP0009745_abnormal_behavioral_response | 1.82119324 |
| 25 | MP0001486_abnormal_startle_reflex | 1.81277755 |
| 26 | MP0002272_abnormal_nervous_system | 1.75523166 |
| 27 | MP0002064_seizures | 1.74743980 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.73951731 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.67490899 |
| 30 | MP0004043_abnormal_pH_regulation | 1.65614748 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.63651834 |
| 32 | MP0004270_analgesia | 1.62303903 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.60862561 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.60811355 |
| 35 | MP0001764_abnormal_homeostasis | 1.59063495 |
| 36 | MP0002736_abnormal_nociception_after | 1.56708806 |
| 37 | MP0003186_abnormal_redox_activity | 1.55726390 |
| 38 | MP0009046_muscle_twitch | 1.52930617 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.52095088 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.50854798 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.49468566 |
| 42 | MP0001984_abnormal_olfaction | 1.48216763 |
| 43 | MP0003136_yellow_coat_color | 1.46139970 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 1.42322004 |
| 45 | MP0003635_abnormal_synaptic_transmissio | 1.40197302 |
| 46 | MP0001485_abnormal_pinna_reflex | 1.39260189 |
| 47 | MP0003868_abnormal_feces_composition | 1.37564735 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.31325930 |
| 49 | MP0002971_abnormal_brown_adipose | 1.28886877 |
| 50 | MP0002063_abnormal_learning/memory/cond | 1.28759085 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.28475537 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.28034937 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.27732928 |
| 54 | MP0004885_abnormal_endolymph | 1.27278099 |
| 55 | MP0001756_abnormal_urination | 1.26894470 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.26707146 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.25123922 |
| 58 | MP0005451_abnormal_body_composition | 1.24051459 |
| 59 | MP0004215_abnormal_myocardial_fiber | 1.22698140 |
| 60 | MP0003879_abnormal_hair_cell | 1.21280792 |
| 61 | MP0005535_abnormal_body_temperature | 1.19309687 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.16192038 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.15951931 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.15116052 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.14126775 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 1.12662952 |
| 67 | MP0001661_extended_life_span | 1.10160251 |
| 68 | MP0002102_abnormal_ear_morphology | 1.09948662 |
| 69 | MP0004142_abnormal_muscle_tone | 1.08171191 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.08085057 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.07005682 |
| 72 | MP0005647_abnormal_sex_gland | 1.06467677 |
| 73 | MP0005386_behavior/neurological_phenoty | 1.03797432 |
| 74 | MP0004924_abnormal_behavior | 1.03797432 |
| 75 | MP0002254_reproductive_system_inflammat | 1.03583971 |
| 76 | MP0005187_abnormal_penis_morphology | 1.02714223 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 1.02679258 |
| 78 | MP0005334_abnormal_fat_pad | 1.01828620 |
| 79 | MP0000566_synostosis | 1.01041466 |
| 80 | MP0000604_amyloidosis | 1.00797588 |
| 81 | MP0000598_abnormal_liver_morphology | 1.00283553 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 0.97642386 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.97298061 |
| 84 | MP0003633_abnormal_nervous_system | 0.97187238 |
| 85 | MP0005253_abnormal_eye_physiology | 0.97110153 |
| 86 | MP0002067_abnormal_sensory_capabilities | 0.96273575 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.96044300 |
| 88 | MP0003690_abnormal_glial_cell | 0.95592293 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.93532732 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.92730299 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.92716144 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.91141350 |
| 93 | MP0000778_abnormal_nervous_system | 0.90421051 |
| 94 | MP0009764_decreased_sensitivity_to | 0.90359511 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.89387984 |
| 96 | MP0003329_amyloid_beta_deposits | 0.88054903 |
| 97 | MP0003011_delayed_dark_adaptation | 0.86676849 |
| 98 | MP0003122_maternal_imprinting | 0.86613953 |
| 99 | MP0001970_abnormal_pain_threshold | 0.86573911 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.85643885 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.85102288 |
| 102 | MP0001440_abnormal_grooming_behavior | 0.84591002 |
| 103 | MP0009697_abnormal_copulation | 0.83686264 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.82626960 |
| 105 | MP0002938_white_spotting | 0.80992267 |
| 106 | MP0003646_muscle_fatigue | 0.80850030 |
| 107 | MP0002733_abnormal_thermal_nociception | 0.80366111 |
| 108 | MP0003631_nervous_system_phenotype | 0.79434839 |
| 109 | MP0009763_increased_sensitivity_to | 0.79411988 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.77529350 |
| 111 | MP0001502_abnormal_circadian_rhythm | 0.77248717 |
| 112 | MP0003787_abnormal_imprinting | 0.77048803 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.76500942 |
| 114 | MP0002090_abnormal_vision | 0.76428984 |
| 115 | MP0002229_neurodegeneration | 0.75880719 |
| 116 | MP0005377_hearing/vestibular/ear_phenot | 0.75765602 |
| 117 | MP0003878_abnormal_ear_physiology | 0.75765602 |
| 118 | MP0009115_abnormal_fat_cell | 0.75338538 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.74469370 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.74354755 |
| 121 | MP0001905_abnormal_dopamine_level | 0.74076441 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.73552567 |
| 123 | MP0003632_abnormal_nervous_system | 0.72838096 |
| 124 | MP0005448_abnormal_energy_balance | 0.72577342 |
| 125 | MP0004133_heterotaxia | 0.72439273 |
| 126 | MP0000026_abnormal_inner_ear | 0.71919757 |
| 127 | MP0004742_abnormal_vestibular_system | 0.71583419 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.71311896 |
| 129 | MP0005220_abnormal_exocrine_pancreas | 0.69713033 |
| 130 | MP0008469_abnormal_protein_level | 0.69168885 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.65652838 |
| 132 | MP0005266_abnormal_metabolism | 0.64785008 |
| 133 | MP0010368_abnormal_lymphatic_system | 0.62759286 |
| 134 | MP0002168_other_aberrant_phenotype | 0.61066975 |
| 135 | MP0003953_abnormal_hormone_level | 0.60379120 |
| 136 | MP0005330_cardiomyopathy | 0.59718815 |
| 137 | MP0003959_abnormal_lean_body | 0.59662625 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.58846294 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.57781499 |
| 140 | MP0005408_hypopigmentation | 0.57088224 |
| 141 | MP0002970_abnormal_white_adipose | 0.57006309 |
| 142 | MP0009780_abnormal_chondrocyte_physiolo | 0.52154317 |
| 143 | MP0003638_abnormal_response/metabolism_ | 0.49330932 |
| 144 | MP0002796_impaired_skin_barrier | 0.48895121 |
| 145 | MP0002269_muscular_atrophy | 0.47535879 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.44994680 |
| 147 | MP0005395_other_phenotype | 0.44387797 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.43943349 |
| 149 | MP0003075_altered_response_to | 0.43151407 |
| 150 | MP0002928_abnormal_bile_duct | 0.41440236 |
| 151 | MP0006138_congestive_heart_failure | 0.40699692 |
| 152 | MP0005452_abnormal_adipose_tissue | 0.40478715 |
| 153 | MP0004147_increased_porphyrin_level | 0.40079461 |
| 154 | MP0000639_abnormal_adrenal_gland | 0.39119238 |
| 155 | MP0000003_abnormal_adipose_tissue | 0.38910090 |
| 156 | MP0000013_abnormal_adipose_tissue | 0.38695040 |
| 157 | MP0008874_decreased_physiological_sensi | 0.38482754 |
| 158 | MP0002332_abnormal_exercise_endurance | 0.38171135 |
| 159 | MP0008438_abnormal_cutaneous_collagen | 0.38020767 |
| 160 | MP0002135_abnormal_kidney_morphology | 0.36940506 |
| 161 | MP0009672_abnormal_birth_weight | 0.36933831 |
| 162 | MP0003724_increased_susceptibility_to | 0.36261565 |
| 163 | MP0005620_abnormal_muscle_contractility | 0.35882516 |
| 164 | MP0008872_abnormal_physiological_respon | 0.35376820 |
| 165 | MP0004782_abnormal_surfactant_physiolog | 0.35213111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.93350287 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.66395778 |
| 3 | Hyperglycinuria (HP:0003108) | 5.53750928 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.45362954 |
| 5 | Xanthomatosis (HP:0000991) | 5.38526027 |
| 6 | Abnormality of glycine metabolism (HP:0010895) | 5.11583175 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.11583175 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.94671786 |
| 9 | Ketosis (HP:0001946) | 4.91771119 |
| 10 | Hyperglycinemia (HP:0002154) | 4.81135460 |
| 11 | Hyperammonemia (HP:0001987) | 4.79866046 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.56457578 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56229310 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.48320114 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.40487249 |
| 16 | Complement deficiency (HP:0004431) | 4.38616220 |
| 17 | Ketoacidosis (HP:0001993) | 4.27908901 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.26635904 |
| 19 | Hypoglycemic coma (HP:0001325) | 4.22538995 |
| 20 | Gout (HP:0001997) | 3.98799998 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.88787779 |
| 22 | Epidermoid cyst (HP:0200040) | 3.83043777 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.79391035 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.77493586 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.75187917 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.57808286 |
| 27 | Hypomagnesemia (HP:0002917) | 3.56980810 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.51446481 |
| 29 | Abnormality of purine metabolism (HP:0004352) | 3.50770112 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.37316156 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 3.37316156 |
| 32 | Joint hemorrhage (HP:0005261) | 3.33187800 |
| 33 | Fat malabsorption (HP:0002630) | 3.28631836 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.26464921 |
| 35 | Generalized aminoaciduria (HP:0002909) | 3.25752300 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.25584001 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.22093583 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.20102111 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.20028012 |
| 40 | Proximal tubulopathy (HP:0000114) | 3.13697369 |
| 41 | Focal motor seizures (HP:0011153) | 3.11984717 |
| 42 | Metabolic acidosis (HP:0001942) | 3.08911661 |
| 43 | Abnormality of complement system (HP:0005339) | 3.02873559 |
| 44 | Increased purine levels (HP:0004368) | 3.00422472 |
| 45 | Hyperuricemia (HP:0002149) | 3.00422472 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.94018154 |
| 47 | Lethargy (HP:0001254) | 2.91609134 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.88608381 |
| 49 | Polyuria (HP:0000103) | 2.88530765 |
| 50 | Abnormality of magnesium homeostasis (HP:0004921) | 2.79482847 |
| 51 | Hydroxyprolinuria (HP:0003080) | 2.79016710 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 2.79016710 |
| 53 | Polydipsia (HP:0001959) | 2.75383516 |
| 54 | Abnormal drinking behavior (HP:0030082) | 2.75383516 |
| 55 | Hyperventilation (HP:0002883) | 2.73638186 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.72703896 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.71070598 |
| 58 | Hyperalaninemia (HP:0003348) | 2.66459920 |
| 59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.66459920 |
| 60 | Abnormality of alanine metabolism (HP:0010916) | 2.66459920 |
| 61 | Alkalosis (HP:0001948) | 2.59267603 |
| 62 | Hyperaldosteronism (HP:0000859) | 2.58711041 |
| 63 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.58543811 |
| 64 | Cerebral edema (HP:0002181) | 2.57767073 |
| 65 | Vascular calcification (HP:0004934) | 2.57127666 |
| 66 | Vomiting (HP:0002013) | 2.55027733 |
| 67 | Skin nodule (HP:0200036) | 2.53929240 |
| 68 | Myocardial infarction (HP:0001658) | 2.51174571 |
| 69 | Steatorrhea (HP:0002570) | 2.49884073 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.48302622 |
| 71 | Myokymia (HP:0002411) | 2.47089127 |
| 72 | Myoglobinuria (HP:0002913) | 2.45797364 |
| 73 | Abnormality of renin-angiotensin system (HP:0000847) | 2.42908548 |
| 74 | Hypoglycemic seizures (HP:0002173) | 2.42258933 |
| 75 | Hypothermia (HP:0002045) | 2.39654409 |
| 76 | Abnormality of renal excretion (HP:0011036) | 2.38825250 |
| 77 | Pancreatic cysts (HP:0001737) | 2.38544779 |
| 78 | Pancreatitis (HP:0001733) | 2.35980388 |
| 79 | Focal seizures (HP:0007359) | 2.34837990 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 2.33603297 |
| 81 | Glycosuria (HP:0003076) | 2.33603297 |
| 82 | Renal salt wasting (HP:0000127) | 2.31272405 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.31024400 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.29725230 |
| 85 | Irritability (HP:0000737) | 2.29345103 |
| 86 | Hypokalemia (HP:0002900) | 2.28130358 |
| 87 | Neonatal onset (HP:0003623) | 2.26468488 |
| 88 | Enlarged kidneys (HP:0000105) | 2.25510154 |
| 89 | Malnutrition (HP:0004395) | 2.22354951 |
| 90 | Hypokalemic alkalosis (HP:0001949) | 2.20909926 |
| 91 | Late onset (HP:0003584) | 2.20175492 |
| 92 | Spastic diplegia (HP:0001264) | 2.19554310 |
| 93 | Hyperphosphaturia (HP:0003109) | 2.17135119 |
| 94 | Abnormality of the renal cortex (HP:0011035) | 2.12908607 |
| 95 | Nausea (HP:0002018) | 2.11982940 |
| 96 | Hemiparesis (HP:0001269) | 2.11775789 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 2.11681782 |
| 98 | Febrile seizures (HP:0002373) | 2.06731623 |
| 99 | Increased circulating renin level (HP:0000848) | 2.05719789 |
| 100 | Hypertriglyceridemia (HP:0002155) | 2.05180177 |
| 101 | Abnormal biliary tract physiology (HP:0012439) | 2.03690589 |
| 102 | Bile duct proliferation (HP:0001408) | 2.03690589 |
| 103 | Abnormality of chloride homeostasis (HP:0011422) | 2.03004043 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.02821380 |
| 105 | Cholelithiasis (HP:0001081) | 2.01549650 |
| 106 | Fair hair (HP:0002286) | 2.00637160 |
| 107 | Renal cortical cysts (HP:0000803) | 2.00115222 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.99843167 |
| 109 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99164334 |
| 110 | Rickets (HP:0002748) | 1.98621598 |
| 111 | Methylmalonic acidemia (HP:0002912) | 1.96026829 |
| 112 | Brushfield spots (HP:0001088) | 1.95136790 |
| 113 | Acute encephalopathy (HP:0006846) | 1.94975521 |
| 114 | Tubular atrophy (HP:0000092) | 1.94611786 |
| 115 | Spontaneous abortion (HP:0005268) | 1.93512005 |
| 116 | Methylmalonic aciduria (HP:0012120) | 1.92166017 |
| 117 | Hyperactive renin-angiotensin system (HP:0000841) | 1.90119892 |
| 118 | True hermaphroditism (HP:0010459) | 1.89375056 |
| 119 | Medial flaring of the eyebrow (HP:0010747) | 1.86590405 |
| 120 | Chronic hepatic failure (HP:0100626) | 1.86195099 |
| 121 | Potter facies (HP:0002009) | 1.85897996 |
| 122 | Facial shape deformation (HP:0011334) | 1.85897996 |
| 123 | Generalized tonic-clonic seizures (HP:0002069) | 1.85415675 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85011517 |
| 125 | Esophageal varix (HP:0002040) | 1.84876419 |
| 126 | Pancreatic fibrosis (HP:0100732) | 1.84342903 |
| 127 | Metabolic alkalosis (HP:0200114) | 1.82710725 |
| 128 | Status epilepticus (HP:0002133) | 1.82666434 |
| 129 | Hyperglycemia (HP:0003074) | 1.82314893 |
| 130 | Nephrolithiasis (HP:0000787) | 1.82290284 |
| 131 | Large for gestational age (HP:0001520) | 1.81929351 |
| 132 | Mitral stenosis (HP:0001718) | 1.81467926 |
| 133 | Progressive cerebellar ataxia (HP:0002073) | 1.81200035 |
| 134 | Congenital stationary night blindness (HP:0007642) | 1.80706836 |
| 135 | Epileptic encephalopathy (HP:0200134) | 1.80634867 |
| 136 | Increased serum pyruvate (HP:0003542) | 1.80116711 |
| 137 | Abnormality of potassium homeostasis (HP:0011042) | 1.79795860 |
| 138 | Abnormal urine output (HP:0012590) | 1.79347577 |
| 139 | Rhabdomyolysis (HP:0003201) | 1.79007669 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.78838558 |
| 141 | Gait imbalance (HP:0002141) | 1.78313580 |
| 142 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78285197 |
| 143 | Dialeptic seizures (HP:0011146) | 1.77244438 |
| 144 | Decreased central vision (HP:0007663) | 1.76294487 |
| 145 | Abnormality of vitamin metabolism (HP:0100508) | 1.73808189 |
| 146 | Opisthotonus (HP:0002179) | 1.73198538 |
| 147 | Glomerulonephritis (HP:0000099) | 1.72676449 |
| 148 | Amyloidosis (HP:0011034) | 1.72418706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.93867239 |
| 2 | SIK1 | 3.81498975 |
| 3 | ERN1 | 3.11122107 |
| 4 | WNK4 | 3.09305239 |
| 5 | CASK | 2.92389442 |
| 6 | TRIB3 | 2.88709220 |
| 7 | FGFR4 | 2.84829381 |
| 8 | PDK3 | 2.61096985 |
| 9 | PDK4 | 2.61096985 |
| 10 | INSRR | 2.56583388 |
| 11 | WNK3 | 2.45572912 |
| 12 | OXSR1 | 2.41402045 |
| 13 | NTRK3 | 2.25795826 |
| 14 | BMPR1B | 2.14170398 |
| 15 | MARK1 | 2.09843475 |
| 16 | PKN2 | 2.03955378 |
| 17 | CAMK1D | 1.84660081 |
| 18 | ACVR1B | 1.83351337 |
| 19 | MST1R | 1.82965610 |
| 20 | GRK1 | 1.74889704 |
| 21 | PINK1 | 1.74370457 |
| 22 | PDK2 | 1.73452176 |
| 23 | STK39 | 1.73369501 |
| 24 | MAP4K2 | 1.71568541 |
| 25 | MAPK13 | 1.70075411 |
| 26 | TNIK | 1.65902510 |
| 27 | LMTK2 | 1.55722644 |
| 28 | NTRK2 | 1.55188056 |
| 29 | MAP2K4 | 1.53478007 |
| 30 | STK38L | 1.48459521 |
| 31 | ERBB4 | 1.47785955 |
| 32 | LATS1 | 1.41600225 |
| 33 | ADRBK2 | 1.40584026 |
| 34 | FRK | 1.40414064 |
| 35 | PNCK | 1.39258326 |
| 36 | PRKAA2 | 1.33918964 |
| 37 | PRKCG | 1.33442544 |
| 38 | NUAK1 | 1.30062308 |
| 39 | FLT3 | 1.29628793 |
| 40 | FGFR2 | 1.28020231 |
| 41 | MAPK11 | 1.27406137 |
| 42 | MAP3K4 | 1.26539945 |
| 43 | TAOK3 | 1.26100830 |
| 44 | PAK6 | 1.25412406 |
| 45 | PIK3CG | 1.23661375 |
| 46 | CAMK1G | 1.22504691 |
| 47 | MAP3K7 | 1.21906681 |
| 48 | PLK2 | 1.19506379 |
| 49 | TIE1 | 1.15215265 |
| 50 | PHKG2 | 1.13687393 |
| 51 | PHKG1 | 1.13687393 |
| 52 | SGK223 | 1.11670987 |
| 53 | SGK494 | 1.11670987 |
| 54 | AKT3 | 1.09657567 |
| 55 | MKNK2 | 1.07243673 |
| 56 | NEK9 | 1.04504836 |
| 57 | PTK6 | 1.04403913 |
| 58 | SGK3 | 1.02662183 |
| 59 | ZAK | 0.99058807 |
| 60 | RIPK1 | 0.97393796 |
| 61 | PRKAA1 | 0.97160023 |
| 62 | CSNK1G2 | 0.96276295 |
| 63 | PRKCE | 0.90244901 |
| 64 | CSNK1G1 | 0.89693211 |
| 65 | DAPK2 | 0.88097947 |
| 66 | MAP2K3 | 0.87916739 |
| 67 | SGK2 | 0.87877732 |
| 68 | JAK2 | 0.87676524 |
| 69 | EPHB1 | 0.87448011 |
| 70 | MET | 0.86266169 |
| 71 | TRIM28 | 0.85477254 |
| 72 | NEK1 | 0.84373264 |
| 73 | CAMK1 | 0.84263378 |
| 74 | MINK1 | 0.84088530 |
| 75 | CAMK2A | 0.84074985 |
| 76 | PKN1 | 0.82454049 |
| 77 | MUSK | 0.80815818 |
| 78 | MAPK12 | 0.80804306 |
| 79 | ABL2 | 0.79921992 |
| 80 | OBSCN | 0.79387675 |
| 81 | PDPK1 | 0.78820924 |
| 82 | WEE1 | 0.78319307 |
| 83 | PIK3CA | 0.76065931 |
| 84 | MYLK | 0.75184436 |
| 85 | TTN | 0.74585006 |
| 86 | TGFBR2 | 0.73806169 |
| 87 | UHMK1 | 0.73538973 |
| 88 | CAMK2B | 0.72863015 |
| 89 | CAMK2D | 0.72078495 |
| 90 | MAP3K3 | 0.72067885 |
| 91 | CAMKK2 | 0.71907485 |
| 92 | GSK3A | 0.71306195 |
| 93 | DYRK2 | 0.71149774 |
| 94 | CSNK1G3 | 0.70035308 |
| 95 | JAK1 | 0.69065312 |
| 96 | PRKACG | 0.68099043 |
| 97 | TLK1 | 0.67198837 |
| 98 | CSNK1A1L | 0.66617489 |
| 99 | STK38 | 0.65883450 |
| 100 | PRKACA | 0.64417961 |
| 101 | PRKCZ | 0.63911131 |
| 102 | GRK5 | 0.63781670 |
| 103 | FGFR3 | 0.62932398 |
| 104 | TNK2 | 0.62849458 |
| 105 | TYK2 | 0.62635053 |
| 106 | MAPKAPK5 | 0.62399015 |
| 107 | MAPKAPK3 | 0.61495377 |
| 108 | NLK | 0.59450336 |
| 109 | DYRK1A | 0.58111697 |
| 110 | CSNK1A1 | 0.57714269 |
| 111 | PDK1 | 0.56880957 |
| 112 | PRKG1 | 0.56577042 |
| 113 | CDK5 | 0.54710854 |
| 114 | IRAK2 | 0.54083219 |
| 115 | MAP2K1 | 0.53531833 |
| 116 | PDGFRA | 0.53471487 |
| 117 | PLK3 | 0.52279339 |
| 118 | BRSK2 | 0.50454213 |
| 119 | RET | 0.49575740 |
| 120 | CAMK2G | 0.49025658 |
| 121 | PAK3 | 0.48328866 |
| 122 | CSNK1D | 0.47685527 |
| 123 | MAP2K7 | 0.47303330 |
| 124 | KDR | 0.47140093 |
| 125 | CAMKK1 | 0.46782880 |
| 126 | STK11 | 0.46699236 |
| 127 | FER | 0.46483530 |
| 128 | PRKCA | 0.45627340 |
| 129 | MAPK4 | 0.44642649 |
| 130 | ADRBK1 | 0.43288068 |
| 131 | RPS6KA3 | 0.43054506 |
| 132 | ERBB2 | 0.42825435 |
| 133 | PRKACB | 0.42527816 |
| 134 | ERBB3 | 0.42032614 |
| 135 | ROCK1 | 0.41834832 |
| 136 | WNK1 | 0.41673715 |
| 137 | PRKCH | 0.41128931 |
| 138 | MAP2K6 | 0.41022936 |
| 139 | PRKD3 | 0.40757442 |
| 140 | CDK6 | 0.40254958 |
| 141 | MAPK15 | 0.39512725 |
| 142 | EPHA4 | 0.39484010 |
| 143 | PTK2 | 0.39230072 |
| 144 | PBK | 0.39225024 |
| 145 | IGF1R | 0.35936740 |
| 146 | PRKD1 | 0.35017942 |
| 147 | IRAK1 | 0.34666312 |
| 148 | MAPK7 | 0.32821274 |
| 149 | IRAK3 | 0.32652324 |
| 150 | MTOR | 0.32285434 |
| 151 | DYRK1B | 0.31834148 |
| 152 | MAP3K6 | 0.30932013 |
| 153 | EPHA3 | 0.30267956 |
| 154 | MAP3K2 | 0.27945250 |
| 155 | GRK6 | 0.27934542 |
| 156 | FGFR1 | 0.26196946 |
| 157 | LRRK2 | 0.26052442 |
| 158 | PRKCQ | 0.25117246 |
| 159 | CAMK4 | 0.24126658 |
| 160 | TAOK2 | 0.23474318 |
| 161 | SGK1 | 0.23208503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58994933 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.39330023 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05687552 |
| 4 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.98920700 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.96891364 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.91550319 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.88296244 |
| 8 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.78825257 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61176017 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57443923 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.56111097 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55169459 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.36509095 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33499457 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.28546864 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.21397854 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19671372 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19298302 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00432263 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.97604586 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.83957460 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.82828741 |
| 23 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77317008 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71156671 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58512818 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58144189 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57069904 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55998564 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54262539 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51484573 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51113688 |
| 32 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.48523758 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46215325 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44796288 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44440622 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.43638969 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40200252 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35113709 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.34406072 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32632447 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26761071 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24367824 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23916894 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23458657 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17655371 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16504281 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14469721 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12418104 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09242982 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.08876034 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05595780 |
| 52 | Nicotine addiction_Homo sapiens_hsa05033 | 1.04039203 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.03328544 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00904700 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95698013 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95634471 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.93131466 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89396033 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82611403 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80301992 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76386611 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74104694 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71836624 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69875100 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69091996 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.68520927 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.65054366 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64434448 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60830250 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52626871 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50519477 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49920197 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49013200 |
| 74 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48197394 |
| 75 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48071474 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47725827 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45640035 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.43394207 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42920359 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42395573 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42085203 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.41686543 |
| 83 | Protein export_Homo sapiens_hsa03060 | 0.38118674 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37002750 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36988570 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36063387 |
| 87 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33136674 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.32666590 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31540078 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30077864 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.29303112 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28078197 |
| 93 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27585322 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27383522 |
| 95 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.27069102 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27061865 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25100195 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23636428 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.22817789 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21215144 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.21024439 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19800743 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15024764 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14967606 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.14720027 |
| 106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13172545 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11635626 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10503191 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.09967155 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.06493496 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00508691 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1624139 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1445754 |
| 114 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1221919 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1172579 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1147785 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0975183 |
| 118 | Lysosome_Homo sapiens_hsa04142 | -0.0876929 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0801348 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0760870 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0660168 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0631537 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | -0.0588916 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0525222 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0523436 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0362401 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0114151 |

